A Shandra

D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicity.

S Seeber, U. Vanhoefer, T. Beckers, 2001, Cancer research.